Abstract. In a number of systems phosphorylation of the regulatory light chain (RMLC) of myosin regulates the activity of myosin. In smooth muscle and vertebrate nonmuscle systems RMLC phosphorylation is required for contractile activity. In Dictyostelium discoideum phosphorylation of the RMLC regulates both ATPase activity and motor function. We have determined the site of phosphorylation on the Dictyostelium RMLC and used site-directed mutagenesis to replace the phosphorylated serine with an alanine. The mutant light chain was then expressed in RMLC null Dictyostelium cells (mLCR-) from an actin promoter on an integrating vector. The mutant RMLC was expressed at high levels and associated with the myosin heavy chain. RMLC bearing a ser13ala substitution was not phosphorylated in vitro by purified myosin light chain kinase, nor could phosphate be detected on the mutant RMLC in vivo. The mutant myosin had reduced actin-activated ATPase activity, comparable to fully dephosphorylated myosin. Unexpectedly, expression of the mutant RMLC rescued the primary phenotypic defects of the mlcR-ceils to the same extent as did expression of wild-type RMLC. These results suggest that while phosphorylation of the Dictyostelium RMLC appears to be tightly regulated in vivo, it is not essential for myosin-dependent cellular functions.
M
YOSIN is responsible for force generation in cortical tension (Clarke and Spudich, 1974; Fukui and Yumura, 1986; Pasternak et al., 1989) , cell motility, eytokinesis (Mabuchi and Okuno, 1977; Kiehart et al., 1982; DeLozanne and Spudich, 1987; Knecht and Loomis, 1987; Manstein et al., 1989; Karess et al., 1991; Pollenz et al., 1992) , morphogenesis (Knecht and Loomis, 1987; DeLozanne and Spudich, 1987; Pollenz et al., 1992) , phagoeytosis (Stendahl et al., 1980; Fukui et al., 1990) , and membrane receptor capping (Pasternak et al., 1989; Pollenz et al., 1992) . In the cellular slime mold Dictyostelium discoideum, myosin II is localized in the contractile ring of dividing cells and in the trailing end of loeomoting cells (Yumura and Fukui, 1985) .
Dictyostelium myosin H is a hexamer composed of two 243-kD heavy chains, two 18-kD regulatory light chains, and two 16-kD essential light chains. The molecule consists of two structural and functional domains: an a-helical coiled-coil rod-like tail responsible for filament assembly (Kuczmarski and Spudich, 1980; DeLozanne and Spudich, 1987; Egelhoff et al., 1991) , and a globular head that contains the light chains, actin and ATP-binding sites, and ATPase activity (C6t6 and Bukiejko, 1987; Warrick and Spudich, 1987; Vibert and Cohen, 1988; Korn and Hammer, 1988; Rayment et al., 1993) . Like muscle myosin, Dictyosteliura myosin II can form bipolar thick filaments in vivo (Yumura and Fukui, 1985; Fukui, 1990) and in vitro (Pasternak et al., 1989) .
The activity of Dictyostelium myosin is regulated by a myosin-linked process and exhibits properties of assembly and activation distinct from smooth muscle and vertebrate nonmuscle myosin. Assembly of Dictyostelium myosin into filaments is regulated by phosphorylation at three sites in the carboxyl-terminal 34-kD of the heavy chain (C6t6 and Bukiejko, 1987; Vaillancourt et al., 1988; Luck-Vielmetter et al., 1990) which produces a bending of the tail (Claviez et al., 1982; Kuczmarsld et al., 1987; Vaillancourt et al., 1988; Lock-Vielmetter et al., 1990; Truong et ai., 1992 ). In contrast, bending of the tail of smooth muscle and vertebrate nonmuscle myosin is regulated by light chain phosphorylation. In these systems phosphorylation of regulatory myosin light chain (RMLC) ~ by a Ca2÷-calmodulin dependent MLCK stimulates both assembly and actin-activated ATPase (Suzuki et al., 1978; Somlyo and Somlyo, 1981; Kamm and Stull, 1985; Ikebe et al., 1987; Trybus and Lowey, 1987) , while in Dictyostelium phosphorylation of the RMLC regulates only enzymatic activity (Griflith et al., 1987) .
The Dictyostelium RMLC is phosphorylated in vivo (Kuczmarski and Spudich, 1980 ) by a specific Ca2+-calmodulinindependent myosin light chain kinase in response to cTclic AMP (Berlot et al., 1985; Griflith et al., 1987; Berlot et al., 1987) . RMLC phosphorylation occurs only on serine residues (Berlot et al., 1987) . In vitro, RMLC phosphorylation increases the actin-activated Mg 2÷ ATPase activity of myosin (Griflith et al., 1987; Trybus, 1989) and stimulates motor function as assayed by movement of actin filaments in vitro (Griflith et al., 1987) . Phosphorylation of purified Dictyostelium myosin by cloned Dictyostelium MLCK stimulates actin-activated ATPase three-to sixfold and nearly doubles the rate of actin filament movement in vitro (Uyeda and Spudich, 1993; Ruppel et al., 1994) . RMLC dephosphorylation restores the activity to a basal level (Kuczmarski and Pagone, 1986; Griflith et al., 1987) . Chen et al. (1994) have produced and characterized RMLC null cell lines, in which the single ruleR gene was disrupted by homologous recombination. The ability to reintroduce light chains into a null background provides the opportunity to assess the in vivo consequences of a variety of RMLC mutations. We have employed this system to investigate the function of RMLC phosphorylation in living cells. We determined the site of RMLC phosphorylation by purified, cloned Dictyostelium MLCK (Tan and Spudich, 1991) and used sitedirected mutagenesis to eliminate that phosphorylation site.
When the mutant RMLC is expressed in Dictyostelium it associates with the myosin heavy chain (MHC). Despite its inability to be phosphorylated in vivo, the phosphorylation site mutant rescues the cytokinesis and developmental defects of the RMLC null mutants. Biochemically the mutant myosin exhibits '~30% of the actin activated MgATPase activity of purified wild-type myosin. These results suggest that while phosphorylation of the Dictyostelium RMLC appears to be tightly regulated in vivo, it is not essential for completing cytokinesis or morphogenesis. 
Materials and Methods

Cell Culture and Transformations
Dictyostelium discoideum RMLC null cells (strains 43E9, 45E12, and GllDS) have been previously described (Chen et ai., 1994) . RMLC null cells ofail three strains were transfected with 5-/~g plasmid DNA by electroporation (Howard et ai., 1988) using a BioRad gene pulser at settings 3/~F, 1.3 kV, 25 Ohm, 1 ms time constant. One day after electroporation, media was replaced with HL5 containing 10 t~g/ml G418 (Geneticin; Sigma). To establish cell lines, transformants were cloned by plating on Klebsiella aerogenes lawns and cells from well-isolated plaques were grown in HL5.
Oligonucleotide-directed Mutagenesis
A full-length RMLC cDNA (Tafuri et al., 1989) in pBluescript (Stratagene Inc., La Jolla, CA) was used as the template for PCR-based mutagenesis. PCR using synthetic primer pair A (5'-GTAAAACGACGC~CAGT-Y) and B (5'-CTACAGAGC~CTCTTCTCTG-3~ produced a 5' product where the codon for Serl3 ('ICA) was changed to Ala (GCC) generating a novel StuI restriction site (see Fig. 2 a) . PCR using primer pair C (5'-CAGAGA-AGAGC~CTCTGTAG-3~ and D (5'-AACAGCTATGACCATG-39 produced a 3' product with the same nucleotide substitutions and StuI site. The 5' and 3' PCR products were digested with PstI and StuI or StuI and Baml-II, respectively, and gel purified. The fragments were ligated together into Pstl and BamHI-digested pBhiescript vector and sequenced to assure that no additional mutations were introduced by the Taq polymerase. These manipulations restored the reading frame and produced the desired Ser13 to Alal3 codon change. The same strategy was employed to change the codon for Serl4 (TCT) to Alal4 (GCT) using primer pairs A and E (5'-AACTAC-AGCTGATTCTTCTC-3~ and C and F (5'-GAAGAATCAGCTGTAGTT-3~ which introduce a novel PvuII site. PCR using primer pair C and G (5'-GGGATCCTTATAAATCTTCTTCTGAAATTAATTTTTGTTCTTTT-TTACTGAAGAGAG-3') inserted 30 nucleotides encoding a 10-amino acid epitope of the myc oncogene (EQKLISEEDL, Evan et al., 1985) immediately 5' to the TAA stop codon of the eDNA.
Vector Construction
Escherichia coil Expression Vectors. PCR was used to remove the untranslated portions of the wild-type RMLC and $13A RMLC cDNAs for subcloning into E. coli expression vector pET3d (Novagen Inc., Madison, WI). PCR was done using primer pair H (5"TCfo-CCTCAACCAAAAGAAGAT-TAAAC-3~ and I (5'-ACTTTATTTTTTACTGAAGAGAGTATT-3') with the wild-type or $13A eDNA as template. The PCR products were subcioned in the svnse orientation into the filled-in NdeI site of pET3d, and sequenced. These manipulations inserted the eDNA between a T7 promoter and a T7 terminator and fused 61 nucleotides encoding a six-histidine tag and a thrombin cleavage site to the 5' end of the RMLC such that a fusion protein was expressed under control of the T7 promoter.
Dictyostelium Expression Vectors. The methionine initiator codon of the Dictyostelium actin 15 gene (Knecht et ai., 1986 ) was mutated to a BamHI site and the 270-bp BglII-BamHI promoter fragment was subcloned into pBhiescript (Pollenz et ai., 1992) . A 600-bp BamI-II-HindIH (filled-in) fragment of pDNeo2 (gift of A. Ncegel, Max Plank Institute, Martinsreid, Germany) containing the Dictyostelium actin 8 terminator (McKeown and Firtel, 1981) was subcloned downstream of the mutated actin promoter to produce pBVIT. The 2-kb XbaI neomycin phosphotransferase cassette of pDNeo2 was subcloned into the HindIII (filled-in) site of pBV17 to produce pBORP (see Fig. 3 A) . W'fld-type RMLC eDNA, and wild-type and mutant myc-tagged RMLC cDNAs were subcloned in the sense orientation into the BamI-II site between the actin promoter and terminator to produce, respectively, pBVN519, pBVN5131, pBVN5115, and pBVN5133.
Protein Preparation
Recombinant RMLC. The pET3d expression constructs were transformed into E. coli BL21(DE3). This strain produces T7 RNA polymerase in response to IPTG induction. Bacterial cultures were grown to At00 = 0.8, at which time IFIG was added to 0.4 mM and incubated for another 3 h. Cells were sonicated in IMAC-5 (20 mM Tris-HC1, pH 7.9, 0.5 M NaCI, 10% glycerol, 1 mM PMSF, 5 mM imidazole). The lysate was clarified by centrifugation, filtered through a 0.45-/zm membrane (Costar Corp., Cambridge, MA), and loaded on a His-Bind resin column (Novagen). Histagged RMLC was eluted with 60% IMAC-200 (IMAC-5 with imidazole at 200 raM), dialyzed against 20 mM Tris-HCl, pH 8.3, lyophilized, resuspended to a concentration of 2 mg/ml in thrombin digestion buffer (20 mM Tris-HCl, pH 8.4, 0.15 M NaCI, 2.5 mM CaC12, 10% glycerol), and digested with human thrombin (Novagen) at a enzyme/substrate ratio of 0.5 units/mg.
Myosin. Myosin was purified from Dictyostelium cells as described by Pollenz et al. (1992) except ammonium sulphate precipitation was avoided and a Superose 6 gel filtration column (Pharmacia LKB Nuclear, Gaithersburg, MD) was used in place of S-500 gel filtration. The concentration of myosin was determined using bovine serum albumin (Cohn Fraction V) as a standard with the BioRad protein assay.
Actin. Chicken muscle actin was purified from acetone powder according to Pardce and Spudich (1982) . On the day of use, 20 nag iyophilized actin was rcsuspended in Buffer A (2 mM Tris-HC1, pH 8.0, 0.2 mM ATP, 0.2 mM calcium chloride, 0.5 mM ~-memaptoethanol, 0.005 % sodium azide), clarified by centrifugation, and the concentration was determined by measuring the A290 and dividing by a correction factor of 0.62 (Uyemura et al., 1978) .
Metabolic Labeling and lmmunoprecipitation of ~2P-labeled Myosin
Metabolic labeling was performed using a protocol generously provided by Dr. Janet Smith (Stanford University, Palo Alto, CA). Cells were harvested at 5 × 106 cells/mi, washed and grown in phosphate-free FM medium for 7 h. The cells were then pelleted and resnspended in phosphate-free FM medium at 5 x l0 T eells/ml. [32P]orthophosphate (100/zCi) was added to 200-t~l aliquots of cells. The cultures were incubated at room temperature for 3 h with end-over-end rotation. Labeled cells were harvested and the myosin heavy chain immunoprecipitated using the 396 MHC-specific monoclonal antibody (generously provided by Dr. G. Gerisch, Max Planck Institute, Martinsreid, Germany) as described by Berlot et al. (1985) . Samples were separated by electrophoresis on 15% polyacrylamide gels and transferred to nitrocellulose.
Electrophoretic Analysis
SDS-PAGE and immunoblotting was performed as described in Pollenz et al. 0992 ) except anti-RMLC mAb 1A2 was reacted at 1:100 dilution overnight, then secondary goat anti-mouse IgG horseradish peroxidase conjugate (Jackson Immunoresearch Labs., Inc., West Grove, PA) was reacted at 1:100,000, and detected by ECL (Amersham).
Urea-glycerol PAGE was performed with a modification of Perrie and Perry (1970) . Myosin (1 #g) in storage buffer was boiled in 2x SDS gel sample buffer, cooled, and urea sample buffer added to produce final concentrations of 4.5 M urea, 10.8 mM Tris-HC1, pH 8.6, 86.4 mM glycine, 0.7 mM EDTA, 0.5 mM DTT. The separating gel was 7.5% acrylamide, 0.28% bisacrylamide, 50% glycerol, 20 mM Tris-HCl, pH 8.6, 160 mM glycine. The stacking gel was 3.5 % acrylamide, 0.13 % bisacrylamide, 50% glycerol, 71 mM Tris-HC1, pH 6.8. The running buffer was 20 mM Tris-HCl, pH 8.6, 160 mM glycine. The samples were run at 4W constant power.
Amino Acid Sequencing
To determine the site of MLCK phosphorylation the sequences of phosphorylated and unphosphorylated RMLC were determined. Thrombindigested recRMLC (8 ttg) was run on 12% SDS-PAGE, transferred to PVDF membrane (Problot; Applied Biosystems Inc., Foster City, CA) for 1.5 hr at 300 mA in 10 mM 3-[eyelohexylamino]-l-propanesulfonic acid (CAPS), pH 11.0, 10 % methanol. The membrane was rinsed in Milli-Q water, stained with 0.1% Coomassie Brilliant Blue in 40 % methanol, 1% acetic acid, and destained in 50% methanol, 1% acetic acid. The recRMLC band was excised from the membrane, rinsed in 10% methanol, dried, and sequenced on a sequanator (477A; Applied Biosystems) on line with a model 120A PTH analyzer. To determine the sequence of phosphorylated RMLC, thrombin-digested recRMLC was treated with MLCK (5/~g) and subjected to urea-glycerol gel electrophoresis to resolve phosphorylated and unphosphorylated RMLC. Protein was transferred to Problott, visualized by autoradiography, and the band corresponding to phosphorylated recRMLC was excised and sequenced as above.
Enzymatic Assays
ATPase. Purified myosin was treated with 5 mM CaCI2, 10 mM Tris-HCl, pH 8.0, 250 mM KCI, or varying concentrations of rabbit muscle aetin in the presence of 10 mM Tris-HCl, pH 7.6, 35 mM KCI, 5 mM MgCI2, 0.2 mM CaC12 at room temperature. Reactions were initiated by the addition of 1 mM ATP containing ,~200,000 cpm//~l [3,32P]-iabeled ATE Released phosphate was measured by the Kind, Otter, and Witman (1986) modification of the method of Follard and Koru (1973) . To each 100-/zl reaction 250 /zl 1:1 bertzene:isobntanol and 50/~120 mM silicotungstic acid/10 mM sulfuric acid was added and rapidly mixed. Following the addition of 50/~1 1 mM KH2PO4 to serve as carrier phosphate, 40/~15 % ammonium molybdate in 4 N H2SO4 was added and vortexed for 10 s. After allowing the mixture to partition for 5 rain, a 50-#1 aliquot of the upper organic phase was recovered and counted in Safety-Solve cocktail (Research Products International Corp., Mount Prospect, IL) in a scintillation counter (LS6800; Beckman Instrs., Carlsbad, CA).
MLCK. Recombinant light chain or whole myosin was treated with recombinant MLCK (a generous gift of J. L. Tan, J. Smith, and J. A. Spudich, Stanford University) in 25 mM Triethunolamine, pH 7.5, 5 mM MgC12, 1 mg/ml BSA, 2 mM ATE 0.05 t~Ci/ml [3,32p] ATP, overnight at 4°C (Tan and Spudich, 1991) . Reactions were precipitated by addition of equal volume 10% ice-cold trichloroacetic acid, the protein pellet was resuspended in 2x SDS gel sample buffer (125 mM Tris-HC1, pH 6.8, 4% SDS, 10% B-mercaptoethanol, 20% glycerol), sonicated, neutralized with ammonium hydroxide fumes, and boiled before being run on PAGE.
Morphological Analysis
Cells were processed for 4',6'-diamidino 2-phenylindole (DAPI) fluorescence and irnmunofluorescence according to Pollenz et al. (1992) . A mouse cell line producing a mAb (396) directed against the Dictyostelium myosin heavy chain (Pagh and Gerisch 1986 ) was a gift from Professor G. Gerisch. The cell culture supernatant was diluted 1:1 in phosphate buffered saline.
Results
Dictyostelium RMLC Is Phosphorylated on Serine 13 by MLCK
In vivo the Dictyostelium RMLC is phosphorylated on serine (Berlot et al., 1987) . There are 11 serines in the 161-amino acid polypeptide predicted from the eDNA sequence (Tafuri et al., 1989) . Comparison with RMLC phosphorylation sites in other organisms suggested the Dictyostelium RMLC phosphorylation site was in the amino terminus of the molecule (Tafuri et al., 1989; Kobayashi et al. 1991) . To determine the site of phosphorylation, we sequenced the amino terminus of the RMLC. Because native RMLC purified from Dictyostelium cells was blocked at the amino terminus we sequenced recombinant RMLC purified from E. coli. Alignment of the sequences of E. coli-expressed RMLC phosphorylated in vitro with cloned Dictyostelium MLCK (Tan and Spudich, 1991) and unphosphorylated recRMLC was used to identify the phosphorylated residue. PTHderivatives of phosphoserine are unstable during the acid cleavage step of Edman degradation (Roach and Wang, 1991) and are read as a blank (Ikebe et al., 1987) . Purified recRMLC was subjected to 26 cycles of PTH-amino acid sequencing. Unphosphorylated RMLC gave the sequence GSHMASTKRRLNREESSVVLGEEQVA. Fig. 1 A shows traces of cycles 15 through 18 of the sequencing reactions performed on unphosphorylated recRMLC. The GSH residues at the NH2 terminus are derived from the histidine tag used for purification. The remainder of the sequence corresponds to the sequence predicted from the RMLC eDNA (Tafuri et al., 1989) . Phosphorylated recRMLC produced the same sequence except that no serine PTH-derivative was detected in cycle 16 (Fig. 1 B) . The missing residue corresponds to Ser-13 of native RMLC.
Oligonucleotide-directed mutagenesis was employed to convert the codon (TCA) for Serl3 of the cDNA to GCC which codes for a nonphosphorylatable Alal3 (Fig. 2 A) . This mutation introduces a novel StuI restriction site into the cDNA. As a control for the amino acid substitution we also mutated Serl4 (TCT) to Alal4 (GCT). This mutation introduces a novel PvulI restriction site into the cDNA.
The S13A RMLC eDNA was expressed in E. coli as a histagged fusion protein. Following purification the expressed RMLC were treated in vitro with MLCK (Fig. 2 B) and no phosphorylation was detected. The lowest limit of our detectability is 0.01 mol phosphage/mol RMLC. This result indicates that serl3 is the principal target for the cloned Dictyostelium MLCK.
Generation of Mutant Cells
To express the mutant RMLC cDNAs in Dictyostelium RMLC null cells, we constructed a Dicryostelium-expression vector, pBORP (Fig. 3 A) , which drives expression of inserted cDNAs from the constitutive actin 15 promoter and contains a neomycin resistance gene for selection of transformed cells, The various cDNAs were subcloned into pBORP to produce constructs pBVN5131 (wild type), pBVN5115 (S13A), and pBVNS133 (S14A). To allow detection of the mutant protein when expressed in wild type cells (for experiments not shown), the cDNAs had been tagged at their 3' end with a 10-amino acid epitope for the myc oncogene (Stappenbeck and Green, 1992) . Three different RMLC null cell lines were transformed separately with each of the three expression constructs. At least three independent cell lines of each transformation were maintained and ana- lyzed. The myc-tagged wild-type RMLC expressing lines behaved in a similar fashion to the untransformed JH10 parental cell line with respect to development and growth in suspension, except for a slightly slower growth rate which is typical of all of the transformed cell lines. RNA from cell lines transformed with the constructs showed about 10-fold overexpression of RMLC mRNA (data not shown). RMLC-myc fusion proteins were detected in transformed cell lysates by western immunoblot using an anti-RMLC monoclonal antibody (IA2). The myc-tagged RMLCs migrate with an apparent molecular mass of 19.5 kD (Fig. 3, B and C) . The mutant RMLC copurifies with myosin (Fig. 4 C) confirming their association with the MHC.
PCR was performed on DNA purified from transformed cell lines to amplify the RMLC coding sequence. The resulting products were digested with StuI or PvulI (data not shown) to test for the presence of the novel restriction sites introduced by the mutagenesis. PeR products from cells transformed with pBVN5131 (WT) did not cut with StuI or PvulI. Only PCR products from cells transformed with pBVN5115 (S13A) cut with StuI and only PCR products from cells transformed with pBVN5133 (S14A) cut with PvulI. These results confirmed the introduced mutations were maintained in vivo.
SI3A R M L C Myosin Is Not Phosphorylated
When myosin purified from S13A and S14A transformed cell lines was treated in vitro with cloned MLCK (Tan and Spudich, 1991) , SI4A (Fig. 4 A, lane 2) , but not S13A (lane /) RMLC was phosphorylated. This result confirms the identification of S13A as the site of phosphorylation by (2), and El2 transformed with wild type (3), S13 A (4), or S14A (5) RMLC cDNAs were lysed and processed for PAGE as described in Materials and Methods. (B) Coomassie-stained 12% polyacrylamide gel, and (C) corresponding immunoblot reacted with the RMLC-specific monoclonal antibody 1A2. No RMLC is detected in null line El2. S13A and S14A RMLC migrate at apparent molecular mass of 19.5 kD due to extra 10-arnino acid COOH-terminal myc epitope tag.
with 32p and myosin was immunoprecipitated using a heavy chain specific antibody. As can be seen in Fig. 4 B, the RMLC is labeled on both wild-type (lane/) and S14A (lane 3) mutants, but not on the S13A mutant (lane 2). Fig. 4 C shows the filter in Fig. 4 B, probed with an RMLC monoclohal antibody to confirm the presence of RMLC in all samples. The presence of similar levels of RMLC in the immunoprecipitates from all three cell lines indicates that the mutant RMLC associate with the MHC with normal stoichiometry. These results clearly demonstrate that the S1 3A mutant is not phosphorylated to any significant extent in vivo. The absence of labeling indicates that serine 13 must be the predominant site of RMLC phosphorylation in vivo. 
$13A RMLC Myosin Exhibits Basal ATPase Activity
The ATPase activities of myosins purified from the mutant and control cell lines were determined. There was no significant difference between the ATPase activity of myosin from wild-type cells or cells overexpressing wild-type myctagged RMLC (data not shown) indicating that neither the G418 drug selection nor the myc tag significantly affects myosin enzymatic activity. S13A myosin had a calcium ATPase activity (V,= = 600 nmol Pi/min/mg) comparable to SI4A and wild-type myosin. However, S13A myosin had an actinactivated ATPase activity (Vm~ = 20 nmol Pi/min/mg) which was 30% that of S14A (Fig. 5 ) and wild-type myosin. This value for S13A myosin is the same as that found for phosphatase-treated myosin in Griflith et al. (1987) . S14A and wild-type myosin exhibit the same activity as untreated, partially phosphorylated myosin in Griflith et al. (1987) .
$13A RMLC Corrects the Developmental Defect of RMLC Null Cell Lines
We next characterized the phenotypes of cell lines expressing the modified RMLCs. The cells are motile and able to undergo cytokinesis on plastic and in shaking culture. When plated on lawns of Klebsiella aerogenes, S13A plaques appeared in four days, one day later than S14A plaques. Fruiting bodies developed in most plaques with a morphology and density indistinguishable from wildtype (Fig. 6 ). Some plaques did not contain fruiting bodies. Cells grown from non-developing plaques were G418 sensitive indicating they had lost the expression plasmid in the absence of drug selection and reverted to the RMLC null phenotype. When transformants were plated on lawns of a G418 resistant E. coli (Hughes et al., 1992) on SM agar containing G418 (100 #g/ml) to maintain selection throughout bacterial growth, normal fruiting bodies appeared in all plaques and contained G418-resistant spores.
$13A Cells Exhibit Normal Myosin Localization
Cells were processed for indirect immunofluorescence and stained with an anti-MHC monoclonai antibody (396). In RMLC null cells, myosin localization is affected in both substrate and suspension cultured cells (Chen et al., 1994) . In suspension cultured RMLC null cells myosin is observed to have a primarily endosomal localization in contrast to the primarily cortical localization seen in wildtype cells. When RMLC null cells were grown on a solid substrate myosin was seen in a normal cortical localization or in intense spots generally found near the posterior cortex. In contrast, myosin in the S13A and S14A mutant cells showed a pattern of localization similar to that seen in wild-type transformed cells (Fig. 7) . Thus, expression of the S13A and S14A mutant light chains corrected the defect in myosin localization observed in the RMLC null cells (Chen et al., 1994) .
$13A RMLC Corrects the Cytokinesis Defect of RMLC Null Cells
When RMLC null cells are grown in suspension they become large and multinucleate due to a defect in cytokinesis (Fig. 8 A) . Null cells transformed with wild type, S13A, and S14A remain mostly mononucleate in suspension (Fig. 8, B , C, and D). Null cells transformed with wild type, S13A, and S14A grow with a doubling time of 18 h (Fig. 9 ). There was a reduction in growth rate of 86 % compared to parental cells of strain JH10 which may be due to the presence of the G418 selection drug. Alternatively, the added metabolic burden of high levels of ectopic expression of RMLC could contribute to decreased growth rate.
Discussion
We have identified the site of phosphorylation on the RMLC of Dictyostelium myosin and used site directed mutagenesis to replace the phosphorylated serine with a non-phosphorylatable alanine. When this mutant light chain is expressed in an RMLC null cell line created by targeted disruption of the RMLC gene, the mutant RMLC corrects the phenotypic defects of the mlcR-cells as well as does expression of wild-type RMLC. By immunoprecipitation of myosin from 32p-labeled cells, we were unable to detect phosphorylation of the mutant RMLC. Although the mutant myosin appears capable of performing the normal cellular functions of myosin, it has a significantly reduced actin-activated ATPase, comparable to that observed in wild-type myosin dephosphorylated by phosphatase treatment. These results suggest that the phosphorylation of the RMLC is not required for cellular functions including cytokinesis and cell movements required for multiceUular morphogenesis. Several lines of evidence have suggested the importance of RMLC phosphorylation. First, phosphorylation of the RMLC in smooth muscle and vertebrate nonmuscle systems is required for significant levels of actin-activated ATPase activity (Kamm and Stull, 1985; Trybus, 1989; Tan et al., 1992) . Second, RMLC phosphorylation has been shown to regulate the actin-activated ATPase activity of myosins from a variety of sources, including Dictyostelium. Phosphorylation also has been shown to regulate motor function as assayed by the movement of actin filaments in vitro (Griflith et al., 1987; Uyeda and Spudich, 1993; Ruppel et al., 1994) .
Third, the phosphorylation of Dictyostelium RMLC is tightly regulated during the aggregation stage of development. Berlot et al. (1985) have shown that phosphorylation of the RMLC increases within 20 s following binding of cyclic AMP to the cell surface cAMP receptor responsible for mediating chemotaxis. The level of RMLC phosphorylation peaks soon thereafter and declines to prestimulation levels by 90-120 s. During this period, 30 s to 2 min following chemotactic stimulation, Dictyostelium cells exhibit the so- called cringe response, in which they round up and stop moving. Fukui and colleagues (Yumura and Fukui, 1985; Nachmias et al., 1989) have also shown that the pattern of myosin staining changes from a predominantly endoplasmic localization to a primarily cortical one in response to chemoattractant. Finally, Dictyostelium expresses a myosin light chain kinase which is highly specific for the Dictyostelium RMLC (Griflith ~t al., 1987) . Taken together, these observations are consistent with a role for RMLC phosphorylation in development. Berlot et ai. (1987) demonstrated that the RMLC is phosphorylated on serine. Based on sequence homology with other RMLCs, it was previously suggested that S14 was the probable phosphorylation site (Tafuri et al., 1989 ; see also Tan et al., 1992, Fig. 3 ). Based on considerations of the local sequence environment surrounding the phosphorylation site, Kobayashi et al. (1991) proposed that the Dictyostelium RMLC was phosphorylated at S13. By comparing amino acid sequence of E. coli-expressed RMLC before and after treatment with cloned Dictyostelium MLCK, we have determined that S13 is phosphorylated by cloned MLCK in vitro. The identification of the MLCK phosphorylation site was confirmed by our observation that a recombinant RMLC, carrying a serine 13 to alanine mutation, expressed in E.
coli, was no longer phosphorylated to any significant degree following treatment with purified Dictyostelium MLCK.
Several studies have shown that the level of phosphorylation regulates the actin-activated ATPase and the ability of Dictyostelium myosin to produce ATP dependent movement of actin filaments in vitro (Griflith et al., 1987; Uyeda and Ruppel et al., 1994) . When purified from vegetative Dictyostelium cells, the RMLC typically carries about 0.3 mol phosphate per mole of RMLC polypeptide. In contrast, myosin purified from ruleR-cells expressing S13A RMLC showed no light chain phosphorylation. Both immunoprecipitation of myosin from 32p-labeled cells and ureaglycerol gel analysis of purified myosin (data not shown) showed no evidence of phosphorylation on S13A RMLC. Myosin carrying the S13A RMLC exhibited levels of calcium ATPase comparable to wild type, although the level of actinactivated ATPase activity was only 25-30% that of wild-type type. Phosphatase treated myosin carrying less than 0.01 mol phosphate per mole of RMLC showed ATPase activities of ,,020 nmol/min/mg protein (Griffith et al., 1987) , corresponding to a turnover rate of ,'~0.09 per s. S13A myosin purified from vegetative cells had comparable levels of actinactivated ATPase activity (also 0.09 per s). This level of actin-activated ATPase activity is also in the range obtained by steady state measurements of dephosphorylated smooth muscle myosin (Sellers et al., 1981; Trybus, 1989) . Thus it appears that the S13A RMLC mutation produced the anticipated result: myosin with actin-activated ATPase activity comparable to unphosphorylated myosin. However, despite the reduced actin-activated ATPase, the S13A RMLC myosin had sufficient function in vivo to rescue the phenotypic defects of the RMLC null cells. RMLC null cells expressing the S13A mutant myosin grew in suspension with a doubling time comparable to cells rescued by wild-type RMLC, and progressed normally through the aggregation and multicellular stages of Dictyostelium development.
It has been proposed that the RMLC can be phosphorylated by kinases other than the MLCK, including both PKC and p34 ~2 kinase. The sequence of the RMLC suggests there are potential sites for phosphorylation by PKC at Ser-3 or Thr-4 and by p34 cdc2 kinase at Ser-3. Since the S13A mutant shows no detectable phosphorylation, it seems unlikely that a significant portion of the RMLC in growing cells is phosphorylated at one or more of these sites. However, a cell cycle-dependent phosphorylation such as has been suggested by Satterwhite et al. (1992) may not have been detectable in our experiments. Assuming the cell population is randomly distributed throughout the cell cycle (which is a minimum of 8 h long) and the period of mitosis where the RMLC would be phosphorylated is shorter than 10-15 rain, the phosphorylation would be below our limit of detection. There has been concern that the characterized Dictyostelium MLCK may not be the only kinase capable of phosphorylating the RMLC (Silveira, L. A., J. A. Smith, and J. A. Spudich, personal communication). Our inability to detect phosphorylation on the S13A mutant suggests that regardless of the kinase responsible for phosphorylation, S13 must be the predominant phosphorylation site on Dictyostelium RMLC.
There have been many studies demonstrating the importance of RMLC phosphorylation for the biochemical properties of myosin thought to correlate with in vivo contractile activity. Many of these studies have used desensitized scallop myosin hybrids reconstituted with foreign light chains (Kendrick-Jones et al., 1976; Sellers et al., 1980; Reinach et al., 1986) , or myosin from which RMLC was removed or exchanged (Lowey et al., 1993; Trybus and Chatman, 1993; Trybus et al., 1994) . These experiments and others have shown that phosphorylation increases the actin activated ATPase of smooth muscle and non-muscle myosins, including Dictyostelium myosin. In addition, phosphorylation is coupled to the initiation of contraction in smooth muscle (Hartshorne and Siemankowski, 1981) and has been shown to promote a conformational change that converts folded myosin monomers into an extended form that is assembly competent.
Given this wealth of in vitro data it seems surprising that a phosphorylation site deficient RMLC functions sufficiently well to complement all of the tested phenotypic defects of a RMLC null mutant. These results question the significance of RMLC phosphorylation in vivo. While it is possible that Dictyostelium is unusual with regard to the function of RMLC phosphorylation, it is comparable to other myosins in structure (Warrick et al., 1986; Pasternak et al., 1989; Schroder et al., 1993) , and in the levels of ATPase activity and motor activity as indicated by rates of movement it produces in in vitro motility assays (Griffith et al., 1987; Uyeda and Spudich, 1993; Ruppel et al., 1994) . Dictyostelium myosin may be unusual in that filament assembly is regulated by myosin heavy chain phosphorylation (Kuczmarski and Spudich, 1980; Egelhoff et al., 1993) , and that the myosin light chain kinase is calcium independent (Griffith et al., 1987; Tan and Spudich, 1990) . In addition, the magnitude of phosphorylation dependent enhancement of actin activated ATPase activity may be somewhat lower for Dictyostelium myosin than for smooth muscle myosin. However, these measurements have been of steady state activity, and may result in an underestimation of the phosphorylationdependent activation of Dictyostelium myosin as has been shown for smooth muscle myosin steady-state measurements (Sellers, 1985) . Alternatively these results may suggest that RMLC phosphorylation plays a more subtle role in regulation than would be detected by the relatively crude assays of growth rate and development timing and competence. For example, phosphorylation could make cytokinesis more efficient by 5 %, producing a 5 % increase in growth rate, which would be difficult to document, but which might lead to a relatively strong evolutionary selection pressure for retaining this regulatory process. In this light it is interesting to note the recent report by Uyeda and Spudich (1993) that a mutant Dictyostelium myosin heavy chain lacking the RMLC-binding domain complements most of the phenotypic defects of a myosin heavy chain null mutant. This mutant myosin has somewhat increased ATPase activity and produced normal rates of actin filament movement using an in vitro motility assay. These results provide independent support for the hypothesis that the regulatory role of RMLC phosphorylation in Dictyostelium is not essential. However, the Uyeda and Spudich results taken together with our report that an mlcR-cell exhibits many of the defects of mhcAcells (Chen et al., 1994) , make it likely that some function provided by the RMLC, perhaps a subtle modulation of function, provides sufficient selective advantage to assure the maintenance of the RMLC and myosin light chain kinase through evolution.
